hibitors (–buvir)Beclabuvir†Dasabuvir#Deleobuvir§Filibuvir§GS-6620§Setrobuvir§Sofosbuvir#Radalbuvir†Uprifosbuvir†Combination drugsElbasvir/grazoprevirGlecaprevir/pibrentasvirLedipasvir/sofosbuvir#Ombitasvir/paritaprevir/ritonavir#Sofosbuvir/daclatasvirSofosbuvir/velpatasvirSofosbuvir/velpatasvir/voxilaprevirPicornavirusviral entry: Pleconaril†Anti-influenza agentsBaloxavir marboxilPimodivir†Umifenoviradamantane derivatives/M2 inhibitors (AdapromineAmantadineRimantadine)neuraminidase inhibitors/release phase (Oseltamivir#ZanamivirPeramivir, Laninamivir†)Multiple/generalInterferonInterferon alfa 2bPeginterferon alfa-2a#Multiple/unknownEICAR§FavipiravirGalidesivir†Remdesivir†Mericitabine†MK-608§NITD008§MoroxydinePresatovir†Ribavirin#/Taribavirin†Triazavirin#WHO-EM‡Withdrawn from marketClinical trials:†Phase III§Never to phase IIIචර්ම රෝග පිළිබද අධ්‍යයන විද්‍යාව යනු සම සහ එහි ව්‍යුත්පන්නයන් (කෙස්, ශ්වේද ග්‍රන්ථි) පිළිබදව අධ්‍යයනය කෙරෙන